Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.

Chaisson, R E; Leuther, M D; Allain, J P; Nusinoff-Lehrman, S; Boone, G S; Feigal, D; Volberding, P

Chaisson, R E; Leuther, M D; Allain, J P; Nusinoff-Lehrman, S; Boone, G S; Feigal, D; Volberding, P.

Affiliation

Chaisson RE; Medical Service, San Francisco General Hospital.

Arch Intern Med ; 148(10): 2151-3, 1988 Oct.

Article in En | MEDLINE | ID: mdl-3263098

Subject(s)

AIDS-Related Complex/drug therapy; Acquired Immunodeficiency Syndrome/drug therapy; HIV Antigens/analysis; HIV/immunology; Zidovudine/therapeutic use; AIDS-Related Complex/immunology; Acquired Immunodeficiency Syndrome/immunology; Double-Blind Method; Drug Evaluation; Humans; Leukocyte Count; Random Allocation; T-Lymphocytes

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Antigens / Zidovudine / AIDS-Related Complex / Acquired Immunodeficiency Syndrome / HIV Type of study: Clinical_trials Limits: Humans Language: En Journal: Arch Intern Med Year: 1988 Type: Article

Search on Google

XML

PubMed Links